Vaccination and Long-Term Follow-up of Post-COVID-19 Complications

Authors

  • Md. Ripon Hossain Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Md. Mejbah Uddin Mithu Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Nasrin Akter Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Md. Shahinur Karim Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Irin Akter Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Mahfuza Mubarak Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh, 4-Green Research Society, Savar, Dhaka, Bangladesh
  • Hasi Rani Saha Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Bidhan Chandra Sarkar Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Md. Shahinul Islam Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh, 4-Green Research Society, Savar, Dhaka, Bangladesh

Keywords:

Cross-sectional study, Post COVID-19 complications, Long COVID, Vaccination

Abstract

In recent years, the coronavirus pandemic disease has been raised to fatal levels in the world. In most cases, the infected person suffers from mild to severe damage to some body organs, like the lungs, with a worse prognosis of COVID-19 related complications. This study reported the progression and persistence of COVID-19 complications even after a post-recovery period, and the effects of vaccination on the remediation of complications among the people of Bangladesh. A cross-sectional study was conducted with direct interviews of 1002 patients in different parts of Bangladesh following a well-organized questionnaire.  Moreover, a systematic follow-up study up to four months has also been carried out to investigate the longevity of post-COVID-19 complications in patients. It is very clear from the obtained results that some sociodemographic parameters like age, occupation, health condition, vaccination, and preexisting health problems are the main risk factors for the degree of health complications after the post-COVID-19 period of infectious people. The vaccination can significantly reduce the severity and longevity of post-COVID complications. In addition, this will be useful for the prediction of possible ways to avoid the complications of long COVID by getting vaccination and health awareness.

References

M. Orlandi et al., “The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress,” Clinical Rheumatology, vol. 39, no. 7, pp. 2043–2047, Jun. 2020, doi: 10.1007/s10067-020-05193-2.

S. J. Halpin et al., “Postdischarge symptoms and rehabilitation needs in survivors of COVID?19 infection: A cross?sectional evaluation,” Journal of Medical Virology, vol. 93, no. 2, pp. 1013–1022, Aug. 2020, doi: 10.1002/jmv.26368.

Centers for Disease Control and Prevention. Late sequelae of COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html Accessed in 2022 (Jun 5).

A. Carfì, R. Bernabei, and F. Landi, “Persistent Symptoms in Patients After Acute COVID-19,” JAMA, vol. 324, no. 6, p. 603, Aug. 2020, doi: 10.1001/jama.2020.12603.

C. W. S. Hoong, M. N. M. E. Amin, T. C. Tan, and J. E. Lee, “Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms,” International Journal of Infectious Diseases, vol. 104, pp. 363–369, Mar. 2021, doi: 10.1016/j.ijid.2021.01.031.

Y. Huang et al., “Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase,” Respiratory Research, vol. 21, no. 1, Jun. 2020, doi: 10.1186/s12931-020-01429-6.

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), Available from: https://coronavirus.jhu.edu/map.html Accessed in 2022 (July 13).

“Home - Johns Hopkins Coronavirus Resource Center,” Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/ (accessed Aug. 02, 2022).

“COVID-19 and Your Health,” Centers for Disease Control and Prevention, Feb. 11, 2020. https://www.cdc.gov/coronavirus/2019-ncov/transmission/index.html (accessed Sep. 21, 2022).

“Coronavirus,” Jun. 14, 2021. https://www.who.int/health-topics/coronavirus#tab=tab_1.(accessed Aug. 22).

A. B. Docherty et al., “Features of 20?133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study,” BMJ, p. m1985, May 2020, doi: 10.1136/bmj.m1985.

F. C. Fang et al., “COVID-19—Lessons Learned and Questions Remaining,” Clinical Infectious Diseases, vol. 72, no. 12, pp. 2225–2240, Oct. 2020, doi: 10.1093/cid/ciaa1654.

T. D. Rozen, “Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu,” Cephalalgia, vol. 40, no. 13, pp. 1406–1409, Nov. 2020, doi: 10.1177/0333102420965132.

F. Ghiasvand, S. Z. Miandoab, H. Harandi, F. S. Golestan, and S. A. S. Alinaghi, “A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case,” Infectious Disorders - Drug Targets, vol. 20, no. 4, pp. 559–562, Oct. 2020, doi: 10.2174/1871526520666200429115535.

P. M. George, C. M. Patterson, A. K. Reed, and M. Thillai, “Lung transplantation for idiopathic pulmonary fibrosis,” The Lancet Respiratory Medicine, vol. 7, no. 3, pp. 271–282, Mar. 2019, doi: 10.1016/s2213-2600(18)30502-2.

M. W. Tenforde et al., “Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020,” MMWR. Morbidity and Mortality Weekly Report, vol. 69, no. 30, pp. 993–998, Jul. 2020, doi: 10.15585/mmwr.mm6930e1.

A. Carfì, R. Bernabei, and F. Landi, “Persistent Symptoms in Patients After Acute COVID-19,” JAMA, vol. 324, no. 6, p. 603, Aug. 2020, doi: 10.1001/jama.2020.12603.

J. E. Rubin and S. E. Crowe, “Celiac Disease,” Annals of Internal Medicine, vol. 172, no. 1, p. ITC1, Jan. 2020, doi: 10.7326/aitc202001070.

C. Huang et al., “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,” The Lancet, vol. 397, no. 10270, pp. 220–232, Jan. 2021, doi: 10.1016/s0140-6736(20)32656-8.

Y. M. Goërtz et al., “Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?,” ERJ Open Research, vol. 6, no. 4, pp. 00542–02020, Sep. 2020, doi: 10.1183/23120541.00542-2020.

S. Halpin, R. O’Connor, and M. Sivan, “Long COVID and chronic COVID syndromes,” Journal of Medical Virology, vol. 93, no. 3, pp. 1242–1243, Oct. 2020, doi: 10.1002/jmv.26587.

K. Yuan et al., “Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review,” Molecular Psychiatry, vol. 26, no. 9, pp. 4982–4998, Feb. 2021, doi: 10.1038/s41380-021-01036-x.

A. Dasgupta, A. Kalhan, and S. Kalra, “Long term complications and rehabilitation of COVID-19 patients,” Journal of the Pakistan Medical Association, no. 0, p. 1, 2020, doi: 10.5455/jpma.32.

H. Ejaz et al., “COVID-19 and comorbidities: Deleterious impact on infected patients,” Journal of Infection and Public Health, vol. 13, no. 12, pp. 1833–1839, Dec. 2020, doi: 10.1016/j.jiph.2020.07.014.

M. A. Hossain et al., “Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors,” BMJ Global Health, vol. 6, no. 12, p. e006838, Dec. 2021, doi: 10.1136/bmjgh-2021-006838.

D. P. Oran and E. J. Topol, “Prevalence of Asymptomatic SARS-CoV-2 Infection,” Annals of Internal Medicine, vol. 174, no. 2, pp. 286–287, Feb. 2021, doi: 10.7326/l20-1285.

J. M. AlJishi et al., “Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia,” Journal of Infection and Public Health, vol. 14, no. 1, pp. 6–11, Jan. 2021, doi: 10.1016/j.jiph.2020.11.002.

W. D. Strain, O. Sherwood, A. Banerjee, V. Van der Togt, L. Hishmeh, and J. Rossman, “The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID,” Vaccines, vol. 10, no. 5, p. 652, Apr. 2022, doi: 10.3390/vaccines10050652.

H. Esmaeilzadeh, A. Sanaei Dashti, N. Mortazavi, H. Fatemian, and M. Vali, “Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children,” BMC Infectious Diseases, vol. 22, no. 1, Mar. 2022, doi: 10.1186/s12879-022-07252-2.

S. Figliozzi et al., “Predictors of adverse prognosis in COVID?19: A systematic review and meta?analysis,” European Journal of Clinical Investigation, vol. 50, no. 10, Aug. 2020, doi: 10.1111/eci.13362.

N. A. Chatterjee and R. K. Cheng, “Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment,” Heart, vol. 106, no. 15, pp. 1119–1121, May 2020, doi: 10.1136/heartjnl-2020-317110.

Downloads

Published

2022-09-27

How to Cite

Md. Ripon Hossain, Md. Mejbah Uddin Mithu, Nasrin Akter, Md. Shahinur Karim, Irin Akter, Mahfuza Mubarak, Hasi Rani Saha, Bidhan Chandra Sarkar, & Islam, M. S. (2022). Vaccination and Long-Term Follow-up of Post-COVID-19 Complications. International Journal of Applied Sciences: Current and Future Research Trends, 15(1), 1–15. Retrieved from https://ijascfrtjournal.isrra.org/index.php/Applied_Sciences_Journal/article/view/1280

Issue

Section

Articles